Hualan Biological Vaccine Inc. (SHE:301207)
China
· Delayed Price · Currency is CNY 15.71
+0.03 (0.19%)
Apr 25, 2025, 2:45 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 9.35 billion as of April 25, 2025. Its market cap has decreased by -32.66% in one year.
Market Cap
9.35B
Enterprise Value
6.43B
Revenue
1.13B
Ranking
n/a
PE Ratio
45.75
Stock Price
15.71
Market Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 9.35B, a decrease of -66.74%. That is a compound annual growth rate of -29.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 9.35B | -10.22% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 325.11B |
| Shenzhen Mindray Bio-Medical Electronics | 262.70B |
| WuXi AppTec | 162.00B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.71B |
| Aier Eye Hospital Group | 116.59B |
| Sichuan Biokin Pharmaceutical | 113.68B |
| Shanghai United Imaging Healthcare | 103.27B |
| Yunnan Baiyao Group Co.,Ltd | 102.86B |